Top Markets
Coin of the day
Icosavax, Inc. Icosavax, Inc.

Icosavax, Inc.

ICVX
Classement en actions #25854
Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing... Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing immunizations against infectious diseases. Leveraging its proprietary virus-like particle (VLP) platform technology, the company primarily focuses its efforts on severe respiratory illnesses. Its developmental portfolio includes several key vaccine candidates: IVX-121, an RSV-targeted vaccine currently undergoing Phase 1/1b clinical trials; IVX-A12, a bivalent candidate designed to target both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV); IVX-241, a candidate specifically designed for hMPV; and IVX-411, a SARS-CoV-2 vaccine based on a receptor binding domain (RBD) sequence antigen, which is also in Phase 1/2 clinical trials. Established in 2017, Icosavax maintains its corporate headquarters in Seattle, Washington.
Prix de l'action
$15.31
Dernière synchronisation: 2024-02-29
Capitalisation boursière
$45.70M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Icosavax, Inc. (ICVX)

Catégorie

Historique des divisions d’actions pour Icosavax, Inc. (ICVX)
L’action Icosavax, Inc. (symbole : ICVX) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 20, 2026.
Une action ICVX achetée avant le Aug 20, 2026 équivaudrait aujourd’hui à 0 actions ICVX.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US